James Trevaskis
Vice President - Obesity and Complications
- Role
- Vice President - Obesity and Complications at Eli Lilly and Company
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About James Trevaskis
Experienced scientist with strong in vivo pharmacology background, with emphasis on identification and validation of novel targets for the potential treatment of metabolic diseases, particularly obesity, diabetes and NASH. Strategically leverage target candidates, as a single agent or in combination, to maximize therapeutic potential. Cross-functional project team leadership for discovery and drug development targets, and nomination of clinical development candidates.Specialties: Pre-clinical in vivo pharmacology assessments of anti-obesity and anti-diabetic therapeutics in rodent models. Extensive background in animal models of NASH, and translational understanding of key clinical compounds. Characterization and validation of novel targets and target combinations using appropriate animal models. Fostering rapid progression of project teams from initiation through to development.
Experience
Vice President - Obesity and Complications
Mar 2026 — Present · Boston, MA, US
Education
University of Melbourne
Bachelor of Science (Honours), Molecular pathology
1994 — 1997
Deakin University
PhD
2000 — 2004
Skills
- Metabolism
- Neuroscience
- Molecular Biology
- Protein Chemistry
- Diabetes
- Drug Development
- Animal Models
- Obesity
- Life Sciences
- Endocrinology
- Drug Discovery
- Cross-Functional Team Leadership
- Cell
- Biomarker Discovery
- Pharmacology
- In Vivo
- Physiology
- Inflammation
- Small Molecules
- Metabolic Diseases
- Peptides
- In Vitro
- Metabolic Syndrome
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.